Malik Rajesh
Chief Medical Officer at G1 Therapeutics, Inc.
- Sold, on record
- $3.9M
- Dollars the filings state
- Form 4 sales
- 27
- Latest Jul 5, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- G1 Therapeutics, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale G1 Therapeutics, Inc.RoutineJul 5, 2023 2023
Sold 1,361 shares at $2.45 ($3k)
Malik Rajesh, Chief Medical Officer
10b5-1 planSold 1% of holdings ($337k position)136,378 shares left0.7x usual sizeFiling
- 2 Form 144 notice G1 Therapeutics, Inc.NoticeDec 11, 2023 +159 days
Filed to sell 33,839 shares ($116k)
Malik Rajesh, Officer
10b5-1 plan23.4x usual sizeFiling
- 3 Form 4 sale G1 Therapeutics, Inc.UnusualDec 11, 2023 same day
Sold 33,839 shares at $3.41 ($115k)
Malik Rajesh, Chief Medical Officer
10b5-1 planSold 19.9% of holdings ($581k position)136,378 shares left23.4x usual sizeFollows a Form 144Filing
- 4 Form 4 sale G1 Therapeutics, Inc.No planJan 4, 2024 +24 days
Sold 3,740 shares at $3.09 ($12k)
Malik Rajesh, Chief Medical Officer
No 10b5-1 planSold 2.2% of holdings ($536k position)169,938 shares left2x usual sizeFiling
- 5 Form 144 notice G1 Therapeutics, Inc.NoticeFeb 12, 2024 +39 days
Filed to sell 28,600 shares ($132k)
Malik Rajesh, Officer
10b5-1 plan9.4x usual sizeFiling
- 6 Form 4 sale G1 Therapeutics, Inc.UnusualFeb 12, 2024 same day
Sold 28,600 shares at $4.62 ($132k)
Malik Rajesh, Chief Medical Officer
10b5-1 planSold 14.4% of holdings ($917k position)169,938 shares left9.4x usual sizeFollows a Form 144Filing
- 7 Form 4 sale G1 Therapeutics, Inc.No planMay 13, 2024 +91 days
Sold 8,151 shares at $4.79 ($39k)
Malik Rajesh, Chief Medical Officer
No 10b5-1 planSold 4.8% of holdings ($814k position)161,787 shares left2.2x usual sizeFiling
- 8 Form 4 sale G1 Therapeutics, Inc.No planJul 5, 2024 +53 days
Sold 2,475 shares at $2.51 ($6k)
Malik Rajesh, Chief Medical Officer
No 10b5-1 planSold 1.5% of holdings ($406k position)159,312 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (29)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 5, 2024 | Jul 8, 2024 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 2,475 | $6k | 1.5% | No plan | SEC |
| May 13, 2024 | May 15, 2024 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 8,151 | $39k | 4.8% | No plan | SEC |
| Feb 12, 2024 | Feb 13, 2024 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 28,600 | $132k | 14.4% | Unusual | SEC |
| Feb 12, 2024 | Feb 12, 2024 | G1 Therapeutics, Inc. | Officer | Form 144 notice | 28,600 | $132k | Notice | SEC | |
| Jan 4, 2024 | Jan 8, 2024 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 3,740 | $12k | 2.2% | No plan | SEC |
| Dec 11, 2023 | Dec 13, 2023 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 33,839 | $115k | 19.9% | Unusual | SEC |
| Dec 11, 2023 | Dec 11, 2023 | G1 Therapeutics, Inc. | Officer | Form 144 notice | 33,839 | $116k | Notice | SEC | |
| Jul 5, 2023 | Jul 7, 2023 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 1,361 | $3k | 1.0% | Routine | SEC |
| Jan 5, 2023 | Jan 5, 2023 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 2,368 | $13k | 2.3% | Plan not stated | SEC |
| Sep 13, 2022 | Sep 16, 2022 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 18,000 | $283k | 19.7% | Plan not stated | SEC |
| Jul 5, 2022 | Jul 6, 2022 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 648 | $3k | 0.9% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 5, 2022 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 1,445 | $15k | 2.2% | Plan not stated | SEC |
| Apr 22, 2021 | Apr 23, 2021 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 15,000 | $331k | 25.7% | Unusual | SEC |
| Mar 23, 2021 | Mar 24, 2021 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 15,000 | $329k | 25.7% | Unusual | SEC |
| Mar 2, 2021 | Mar 4, 2021 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 15,000 | $344k | 25.7% | Unusual | SEC |
| Jan 22, 2021 | Jan 22, 2021 | G1 Therapeutics, Inc. | Chief Medical Officer | Form 4 sale | 15,000 | $310k | 27.2% | Unusual | SEC |
| Dec 10, 2020 | Dec 11, 2020 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 9,000 | $181k | 23.6% | Plan not stated | SEC |
| Dec 17, 2018 | Dec 17, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $113k | 20.4% | Plan not stated | SEC |
| Nov 15, 2018 | Nov 16, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $150k | 20.4% | Plan not stated | SEC |
| Oct 15, 2018 | Oct 15, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $157k | 31.0% | Unusual | SEC |
| Sep 17, 2018 | Sep 19, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $250k | 31.0% | Unusual | SEC |
| Aug 15, 2018 | Aug 17, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $211k | 31.0% | Unusual | SEC |
| Jul 16, 2018 | Jul 17, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $159k | 31.0% | Unusual | SEC |
| Jun 15, 2018 | Jun 18, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $167k | 31.0% | Unusual | SEC |
| May 15, 2018 | May 16, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $175k | 47.3% | Unusual | SEC |
| Apr 16, 2018 | Apr 17, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $136k | 47.3% | Unusual | SEC |
| Mar 15, 2018 | Mar 16, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $144k | 47.3% | Unusual | SEC |
| Feb 15, 2018 | Feb 16, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $76k | 100.0% | Unusual | SEC |
| Jan 16, 2018 | Jan 17, 2018 | G1 Therapeutics, Inc. | Ch. Medical Officer & SVP R&D | Form 4 sale | 3,776 | $87k | 100.0% | Unusual | SEC |